Vitamin D3 Streuli 20`000 I.E. Weichkapseln

Vitamin D3 Streuli 20`000 I.E. Weichkapseln is a medicine authorised by Swissmedic under authorisation number 67937. The authorisation holder is Streuli Pharma AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 14 April 2022 and the authorisation is limited until 13 April 2027. ATC code A11CC05 places the medicine in the group Vitamins.

  • Dispensing category B
  • Authorisation number 67937
  • ATC A11CC05
  • Synthetic medicines
Authorisation data
Authorisation number67937
NameVitamin D3 Streuli 20`000 I.E. Weichkapseln
Full nameVitamin D3 Streuli 20`000 I.E. Weichkapseln
Authorisation holderStreuli Pharma AG
Medicinal product codeSynthetic medicines
Dispensing categoryB · Prescription only
ATC codeA11CC05
First authorisation14 April 2022
Authorisation validity13 April 2027
Strengths
No.NameDispensing categoryAuthorisation date
1Vitamin D3 Streuli 20`000 I.E. WeichkapselnB14 April 2022

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
14Kapsel(n)A11CC0507.02.3.B
212Kapsel(n)A11CC0507.02.3.B

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Vitamin D3 Streuli 20`000 I.E. Weichkapseln authorised in Switzerland?

Yes. Vitamin D3 Streuli 20`000 I.E. Weichkapseln is authorised by Swissmedic under authorisation number 67937, data as of 01 September 2026. The authorisation is limited until 13 April 2027.

Which dispensing category does Vitamin D3 Streuli 20`000 I.E. Weichkapseln have?

Vitamin D3 Streuli 20`000 I.E. Weichkapseln is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.

Who is the authorisation holder of Vitamin D3 Streuli 20`000 I.E. Weichkapseln?

The authorisation holder is Streuli Pharma AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com